First Eagle Investment Management’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

First Eagle Investment Management’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-188,600	Closed	-$243K	–	359
2014 Q2	$243K	Sell	188,600 -238,600	-56%	-$342K	﹤0.01%	256
2014 Q1	$773K	Hold	427,200	–	–	﹤0.01%	219
2013 Q4	$662K	Hold	427,200	–	–	﹤0.01%	229
2013 Q3	$1.04M	Sell	427,200 -22,800	-5%	-$63.1K	﹤0.01%	215
2013 Q2	$1.3M	Buy	+450,000	New	+$1.24M	﹤0.01%	234

Other funds holding ONCY

1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return

RFC

Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $66.2B AUM 46.3% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

VFS

VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

First Eagle Investment Management's ONCY Position: Q3 2014 in Review

First Eagle Investment Management sold out of ONCOLYTICS BIOTECH INC (ONCY) in Q3 2014, closing a stake of 188,600 shares — an estimated $243K sold.

First Eagle Investment Management first reported a position in ONCY in Q2 2013 and held it in 5 quarters. The position peaked at $1.3M in Q2 2013. 30 funds tracked by Wall St. Rank hold ONCY as of Q3 2014.

First Eagle Investment Management reported no remaining ONCOLYTICS BIOTECH INC position as of Q3 2014 after selling out during the quarter.
First Eagle Investment Management sold 188,600 ONCOLYTICS BIOTECH INC shares in Q3 2014, an estimated $243K.
First Eagle Investment Management first reported a position in ONCOLYTICS BIOTECH INC in Q2 2013 and held it in 5 quarters.
First Eagle Investment Management's ONCOLYTICS BIOTECH INC position peaked at $1.3M in Q2 2013.
30 funds tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q3 2014.

Based on First Eagle Investment Management's 13F filing for Q3 2014, filed 13 Nov 2014.